Masimo (MASI) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -56.83% |
| Jan 3, 2026 | -37.08% |
| Sep 27, 2025 | -38.62% |
| Jun 28, 2025 | -35.14% |
| Mar 29, 2025 | -40.01% |
| Dec 28, 2024 | -49.14% |
| Sep 28, 2024 | -18.08% |
| Jun 29, 2024 | -17.04% |
| Mar 30, 2024 | -17.79% |
| Dec 30, 2023 | 5.07% |
| Sep 30, 2023 | -28.60% |
| Jul 1, 2023 | -18.57% |
| Apr 1, 2023 | -14.13% |
| Dec 31, 2022 | 48.77% |
| Oct 1, 2022 | 1.12% |
| Jul 2, 2022 | -16.70% |
| Apr 2, 2022 | -1.99% |
| Jan 1, 2022 | -23.29% |
| Oct 2, 2021 | 15.79% |
| Jul 3, 2021 | 10.83% |
| Apr 3, 2021 | 14.12% |
| Jan 2, 2021 | 17.79% |
| Sep 26, 2020 | 21.15% |
| Jun 27, 2020 | 24.96% |
| Mar 28, 2020 | 27.98% |
| Dec 28, 2019 | 11.36% |
| Sep 28, 2019 | 26.83% |
| Jun 29, 2019 | 26.15% |
| Mar 30, 2019 | 16.91% |
| Dec 29, 2018 | 38.37% |
| Sep 29, 2018 | 29.83% |
| Jun 30, 2018 | 24.52% |
| Mar 31, 2018 | 22.71% |
| Dec 30, 2017 | -21.35% |
| Sep 30, 2017 | 21.46% |
| Jul 1, 2017 | 20.50% |
| Apr 1, 2017 | 26.73% |
| Dec 31, 2016 | 73.97% |
| Oct 1, 2016 | 13.38% |
| Jul 2, 2016 | 12.17% |
| Apr 2, 2016 | 8.72% |
| Jan 2, 2016 | -3.14% |
| Oct 3, 2015 | 2.55% |
| Jul 4, 2015 | 5.63% |
| Apr 4, 2015 | -6.42% |
| Sep 27, 2014 | 2.35% |
| Jun 28, 2014 | 1.17% |